NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys

Chih Ching Yang, Chiang Ting Chien, Ming Hsiou Wu, Ma Ming-Chieh, Chau Fong Chen

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

N-methyl-D-aspartate (NMDA) receptor activated by glutamate/glycine is located in the kidneys. The NMDA receptor subunit NR1 is increased in damaged renal tissue. This study explored the role of NMDA receptors in ischemia-reperfusion-induced renal dysfunction in rats. With Western blot analysis and renal functional assay, NMDA receptor expression was evaluated, as well as its functional role in female Wistar rat kidneys after 45 min of unilateral ischemia followed by 24 h of reperfusion. The effects of intrarenal NMDA receptor agonist and antagonist on renal blood flow (RBF), glomerular filtration rate (GFR), urine volume (UV), sodium (UNaV), and potassium (UKV) excretion were determined. NMDA NR1 was present in the glomeruli, brush-border membrane, and outer medulla but not in the cortex and inner medulla. Homogenous distribution of non-NMDA GluR2/3, sparse kainate KA1, and undetectable group I of metabotropic glutamate receptor were noted in the control kidneys. Ischemia-reperfusion kidneys showed enhanced renal NR1, but not NR2C and GluR2/3 expression, and were associated with decreased GFR/RBF and natriuretic/diuretic responses. Intrarenal NMDA agonists significantly reduced GFR, UV, UNaV, and UKV but had no effect on blood pressure and RBF in sham control and ischemia-reperfusion kidneys. NMDA antagonist D-2-amino-5-phosphonopentanoic acid (D-AP-5) treatment completely abolished NMDA-induced renal dysfunction. D-AP-5 treatment significantly ameliorated ischemia-reperfusion-induced glomerular and tubular dysfunction by restoring decreased GFR, UV, and UNaV levels. Ischemia-reperfusion upregulates renal NMDA NR1 receptor expression, leading to reduced glomerular and tubular function in the kidneys. The NMDA antagonist can ameliorate ischemia- reperfusion-induced renal dysfunction.

Original languageEnglish
Pages (from-to)F1433-F1440
JournalAmerican Journal of Physiology - Renal Physiology
Volume294
Issue number6
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

N-Methyl-D-Aspartate Receptors
Reperfusion
Ischemia
Kidney
N-Methylaspartate
Glomerular Filtration Rate
Renal Circulation
Urine
2-Amino-5-phosphonovalerate
D-Aspartic Acid
Metabotropic Glutamate Receptors
Kainic Acid
Microvilli
Diuretics
Glycine
Wistar Rats
Glutamic Acid
Potassium
Up-Regulation
Western Blotting

Keywords

  • Glutamate
  • Ischemia-reperfusion
  • Kidney
  • Renal function

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys. / Yang, Chih Ching; Chien, Chiang Ting; Wu, Ming Hsiou; Ming-Chieh, Ma; Chen, Chau Fong.

In: American Journal of Physiology - Renal Physiology, Vol. 294, No. 6, 01.06.2008, p. F1433-F1440.

Research output: Contribution to journalArticle

Yang, Chih Ching ; Chien, Chiang Ting ; Wu, Ming Hsiou ; Ming-Chieh, Ma ; Chen, Chau Fong. / NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys. In: American Journal of Physiology - Renal Physiology. 2008 ; Vol. 294, No. 6. pp. F1433-F1440.
@article{db29c089ac0a424e8ac440ea050f2215,
title = "NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys",
abstract = "N-methyl-D-aspartate (NMDA) receptor activated by glutamate/glycine is located in the kidneys. The NMDA receptor subunit NR1 is increased in damaged renal tissue. This study explored the role of NMDA receptors in ischemia-reperfusion-induced renal dysfunction in rats. With Western blot analysis and renal functional assay, NMDA receptor expression was evaluated, as well as its functional role in female Wistar rat kidneys after 45 min of unilateral ischemia followed by 24 h of reperfusion. The effects of intrarenal NMDA receptor agonist and antagonist on renal blood flow (RBF), glomerular filtration rate (GFR), urine volume (UV), sodium (UNaV), and potassium (UKV) excretion were determined. NMDA NR1 was present in the glomeruli, brush-border membrane, and outer medulla but not in the cortex and inner medulla. Homogenous distribution of non-NMDA GluR2/3, sparse kainate KA1, and undetectable group I of metabotropic glutamate receptor were noted in the control kidneys. Ischemia-reperfusion kidneys showed enhanced renal NR1, but not NR2C and GluR2/3 expression, and were associated with decreased GFR/RBF and natriuretic/diuretic responses. Intrarenal NMDA agonists significantly reduced GFR, UV, UNaV, and UKV but had no effect on blood pressure and RBF in sham control and ischemia-reperfusion kidneys. NMDA antagonist D-2-amino-5-phosphonopentanoic acid (D-AP-5) treatment completely abolished NMDA-induced renal dysfunction. D-AP-5 treatment significantly ameliorated ischemia-reperfusion-induced glomerular and tubular dysfunction by restoring decreased GFR, UV, and UNaV levels. Ischemia-reperfusion upregulates renal NMDA NR1 receptor expression, leading to reduced glomerular and tubular function in the kidneys. The NMDA antagonist can ameliorate ischemia- reperfusion-induced renal dysfunction.",
keywords = "Glutamate, Ischemia-reperfusion, Kidney, Renal function",
author = "Yang, {Chih Ching} and Chien, {Chiang Ting} and Wu, {Ming Hsiou} and Ma Ming-Chieh and Chen, {Chau Fong}",
year = "2008",
month = "6",
day = "1",
doi = "10.1152/ajprenal.00481.2007",
language = "English",
volume = "294",
pages = "F1433--F1440",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys

AU - Yang, Chih Ching

AU - Chien, Chiang Ting

AU - Wu, Ming Hsiou

AU - Ming-Chieh, Ma

AU - Chen, Chau Fong

PY - 2008/6/1

Y1 - 2008/6/1

N2 - N-methyl-D-aspartate (NMDA) receptor activated by glutamate/glycine is located in the kidneys. The NMDA receptor subunit NR1 is increased in damaged renal tissue. This study explored the role of NMDA receptors in ischemia-reperfusion-induced renal dysfunction in rats. With Western blot analysis and renal functional assay, NMDA receptor expression was evaluated, as well as its functional role in female Wistar rat kidneys after 45 min of unilateral ischemia followed by 24 h of reperfusion. The effects of intrarenal NMDA receptor agonist and antagonist on renal blood flow (RBF), glomerular filtration rate (GFR), urine volume (UV), sodium (UNaV), and potassium (UKV) excretion were determined. NMDA NR1 was present in the glomeruli, brush-border membrane, and outer medulla but not in the cortex and inner medulla. Homogenous distribution of non-NMDA GluR2/3, sparse kainate KA1, and undetectable group I of metabotropic glutamate receptor were noted in the control kidneys. Ischemia-reperfusion kidneys showed enhanced renal NR1, but not NR2C and GluR2/3 expression, and were associated with decreased GFR/RBF and natriuretic/diuretic responses. Intrarenal NMDA agonists significantly reduced GFR, UV, UNaV, and UKV but had no effect on blood pressure and RBF in sham control and ischemia-reperfusion kidneys. NMDA antagonist D-2-amino-5-phosphonopentanoic acid (D-AP-5) treatment completely abolished NMDA-induced renal dysfunction. D-AP-5 treatment significantly ameliorated ischemia-reperfusion-induced glomerular and tubular dysfunction by restoring decreased GFR, UV, and UNaV levels. Ischemia-reperfusion upregulates renal NMDA NR1 receptor expression, leading to reduced glomerular and tubular function in the kidneys. The NMDA antagonist can ameliorate ischemia- reperfusion-induced renal dysfunction.

AB - N-methyl-D-aspartate (NMDA) receptor activated by glutamate/glycine is located in the kidneys. The NMDA receptor subunit NR1 is increased in damaged renal tissue. This study explored the role of NMDA receptors in ischemia-reperfusion-induced renal dysfunction in rats. With Western blot analysis and renal functional assay, NMDA receptor expression was evaluated, as well as its functional role in female Wistar rat kidneys after 45 min of unilateral ischemia followed by 24 h of reperfusion. The effects of intrarenal NMDA receptor agonist and antagonist on renal blood flow (RBF), glomerular filtration rate (GFR), urine volume (UV), sodium (UNaV), and potassium (UKV) excretion were determined. NMDA NR1 was present in the glomeruli, brush-border membrane, and outer medulla but not in the cortex and inner medulla. Homogenous distribution of non-NMDA GluR2/3, sparse kainate KA1, and undetectable group I of metabotropic glutamate receptor were noted in the control kidneys. Ischemia-reperfusion kidneys showed enhanced renal NR1, but not NR2C and GluR2/3 expression, and were associated with decreased GFR/RBF and natriuretic/diuretic responses. Intrarenal NMDA agonists significantly reduced GFR, UV, UNaV, and UKV but had no effect on blood pressure and RBF in sham control and ischemia-reperfusion kidneys. NMDA antagonist D-2-amino-5-phosphonopentanoic acid (D-AP-5) treatment completely abolished NMDA-induced renal dysfunction. D-AP-5 treatment significantly ameliorated ischemia-reperfusion-induced glomerular and tubular dysfunction by restoring decreased GFR, UV, and UNaV levels. Ischemia-reperfusion upregulates renal NMDA NR1 receptor expression, leading to reduced glomerular and tubular function in the kidneys. The NMDA antagonist can ameliorate ischemia- reperfusion-induced renal dysfunction.

KW - Glutamate

KW - Ischemia-reperfusion

KW - Kidney

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=48249099715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249099715&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00481.2007

DO - 10.1152/ajprenal.00481.2007

M3 - Article

C2 - 18272600

AN - SCOPUS:48249099715

VL - 294

SP - F1433-F1440

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 6

ER -